We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALT market cap is 347.34M. The company's latest EPS is USD -1.2343 and P/E is -3.68.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 37k | 5k | 5k | 5k | 5k |
| Operating Income | -33.62M | -26.79M | -26.75M | -24.77M | -24.87M |
| Net Income | -31.64M | -24.39M | -24.64M | -22.85M | -23.18M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.19M | 4.41M | -68k | 426k | 20k |
| Operating Income | -54.8M | -85.92M | -87.74M | -95.93M | -103.17M |
| Net Income | -49.04M | -97.09M | -84.71M | -88.45M | -95.06M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 210.64M | 188.36M | 173.35M | 147.86M | 139.31M |
| Total Liabilities | 16.54M | 15.42M | 20.82M | 14.49M | 15.8M |
| Total Equity | 194.1M | 172.94M | 152.53M | 133.38M | 123.51M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 245.12M | 218.87M | 206.93M | 210.64M | 139.31M |
| Total Liabilities | 19.24M | 19.73M | 21.64M | 16.54M | 15.8M |
| Total Equity | 225.88M | 199.14M | 185.29M | 194.1M | 123.51M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -75.81M | -16.36M | -34.47M | -61.58M | -79.85M |
| Investing | 13.73M | -39.52M | -43.22M | -42.02M | -28.39M |
| Financing | 86.11M | -261k | -307k | -41k | 10.04M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -34.44M | -78.24M | -62.59M | -75.81M | -79.85M |
| Investing | -72.1M | 87.52M | -73.4M | 13.73M | -28.39M |
| Financing | 213.49M | 65.1M | 56.78M | 86.11M | 10.04M |
| Market Cap | 347.34M |
| Price to Earnings Ratio | -3.68 |
| Price to Sales Ratio | 15.13k |
| Price to Cash Ratio | 9.47 |
| Price to Book Ratio | 2.83 |
| Dividend Yield | - |
| Shares Outstanding | 77.01M |
| Average Volume (1 week) | 1.63M |
| Average Volume (1 Month) | 2.21M |
| 52 Week Change | -41.04% |
| 52 Week High | 11.16 |
| 52 Week Low | 3.553 |
| Spread (Intraday) | 0.06 (1.31%) |
| Company Name | Altimmune Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.altimmune.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
